Rover Diagnostics develops a point-of-care testing device utilizing RT-PCR methodology for rapid diagnostics in clinical settings. Their initial focus is on women's health panels, providing results for conditions like Bacterial Vaginosis in approximately 15 minutes. This technology streamlines the diagnostic process for OB/GYNs, enabling faster treatment initiation.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods for women's health conditions often involve lab-based testing, leading to delays in diagnosis and treatment. These delays can negatively impact patient well-being and increase the time to appropriate care. The need for rapid and accurate point-of-care diagnostics is critical for improving women's health outcomes.
Solution
Rover Diagnostics is developing a point-of-care testing device that brings lab-quality molecular diagnostics to OB/GYN clinics, delivering results in under 20 minutes. Their platform utilizes reverse transcription polymerase chain reaction (RT-PCR) to enable rapid and accurate detection of various women's health conditions. The initial panel focuses on common conditions such as bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. By streamlining the diagnostic process, Rover Diagnostics aims to improve the well-being of millions of women annually through faster diagnosis and treatment.
Target Audience
The primary target audience includes OB/GYN clinics and healthcare providers focused on women's health.
Features
- Point-of-care RT-PCR testing for rapid results (under 20 minutes)
- Initial panel targeting bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis
- Easy-to-use design for streamlined integration into OB/GYN clinical workflows
- "Lightspeed" technology applicable to a broad range of conditions and environments